NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) , a company developing advanced artificial intelligence solutions for clinical trial optimization and ...

Ivarmacitinib is associated with favorable treatment outcomes in patients with moderate to severe AD across subgroups with diverse characteristics.

DAREONTM-9, a phase Ib study of obrixtamig plus topotecan in patients (pts) with advanced small cell lung cancer (SCLC): Interim analysis results. Comprehensive longitudinal immune cell monitoring in ...

Unfortunately, this book can't be printed from the OpenBook. Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.

Secondary analysis of the RESOLVE trial suggests the benefits of graded sensorimotor retraining across patient groups with ...

Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS) Authors retain all rights in any data ...

In a cross-sectional study of female pelvic pain, researchers identified 5 distinct clinical pain subgroups based on pain severity and pain type. Distinct subgroups of pelvic pain in females can be ...